Specificity of Histological Markers of Long-Term CNI Nephrotoxicity in Kidney-Transplant Recipients Under Low-Dose Cyclosporine Therapy

被引:94
|
作者
Snanoudj, R. [1 ,2 ]
Royal, V. [3 ]
Elie, C. [2 ,4 ]
Rabant, M. [2 ,3 ]
Girardin, C. [1 ]
Morelon, E. [1 ]
Kreis, H. [1 ,2 ]
Fournet, J. -C. [2 ,3 ]
Noel, L. -H. [2 ,3 ]
Legendre, C. [1 ,2 ]
机构
[1] Hop Necker Enfants Malad, AP HP, Serv Transplantat Renale Adulte, Paris, France
[2] Univ Paris 05, Paris, France
[3] Hop Necker Enfants Malad, AP HP, Lab Anatomopathol, Paris, France
[4] Hop Necker Enfants Malad, AP HP, Serv Biostat, Paris, France
关键词
Calcineurin inhibitors toxicity; biopsy; histopathology; kidney transplantation; CALCINEURIN INHIBITOR NEPHROTOXICITY; RENAL-ALLOGRAFT RECIPIENTS; GLOMERULAR-FILTRATION-RATE; CHRONIC NEPHROPATHY; COMPETING RISK; REPRODUCIBILITY; PATHOLOGY; CLASSIFICATION; TACROLIMUS; SURVIVAL;
D O I
10.1111/j.1600-6143.2011.03718.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The specificity of chronic histological lesions induced by calcineurin inhibitors (CNI) is often questioned, but few studies have directly compared long-term lesions in renal-transplant patients who received this treatment and those who did not. We therefore conducted a retrospective study of 141 kidney-transplant recipients treated with (n = 48) or without (n = 93) cyclosporine (CsA) to compare the histological lesions observed at 3-month, 24-month and 10-year protocol biopsies. All of the chronic elementary lesions (glomerulosclerosis, interstitial fibrosis, tubular atrophy, arteriolar hyalinosis, fibrointimal thickening) progressed in frequency and severity in both groups, although significantly more in the CsA group. Ten-year biopsy results showed that 92% of patients in the CsA-treated group and 65% in the control group had arteriolar hyalinosis lesions. When we focused on muscular arteriolar hyaline deposits more specific to CsA arteriolopathy, we observed these lesions in 68% of CsA patients and 28% of patients who had never received CsA. CsA was not the sole factor involved in the development of arteriolar hyalinosis and was independently associated with an increased risk of graft loss. In summary, we observed that histological lesions commonly attributed to CsA nephrotoxicity were not sufficiently specific to definitively diagnose CNI nephrotoxicity.
引用
收藏
页码:2635 / 2646
页数:12
相关论文
共 50 条
  • [31] SERUM MARKERS OF HEPATITIS-B VIRUS (HBV) AND KIDNEY-TRANSPLANT IN A LOW-DOSE STEROID REGIMEN
    SQUICCIMARRO, G
    TRIOLO, G
    MESSINA, M
    ROSSETTI, M
    MALFI, B
    STRATTA, P
    SEGOLONI, GP
    VERCELLONE, A
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 387 - 387
  • [32] LOW-DOSE CYCLOSPORINE THERAPY IN TRIPLE-DRUG IMMUNOSUPPRESSION FOR HEART-TRANSPLANT RECIPIENTS
    HAUSEN, B
    DEMERTZIS, S
    ROHDE, R
    ALBES, JM
    SCHAFERS, HJ
    BORST, HG
    ANNALS OF THORACIC SURGERY, 1994, 58 (04): : 999 - 1004
  • [33] Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
    Pihlstrom, Hege K.
    Mjoen, Geir
    Mucha, Soren
    Franke, Andre
    Jardine, Alan
    Fellstrom, Bengt
    Dahle, Dag Olav
    Holdaas, Hallvard
    Melum, Espen
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (05) : 1444 - 1451
  • [34] DIFFERENT SURVIVAL OF LONG-TERM KIDNEY-TRANSPLANT RECIPIENTS TREATED WITH DAILY OR ALTERNATE DAY CORTICOSTEROIDS
    DIPADOVA, F
    DIPALO, FQ
    MORANDI, E
    ELLI, A
    VALLINO, F
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1982, 4 (01): : 43 - 48
  • [35] NATURAL CELL-MEDIATED CYTO-TOXICITY IN LONG-TERM KIDNEY-TRANSPLANT RECIPIENTS
    ONO, Y
    HIRABAYASHI, S
    OHSHIMA, S
    KOIDE, Y
    TRANSPLANTATION PROCEEDINGS, 1981, 13 (02) : 1508 - 1510
  • [36] LOW INCIDENCE OF NEPHROTOXICITY IN LONG-TERM RECIPIENTS OF CYCLOSPORINE FOLLOWING BONE-MARROW TRANSPLANTATION
    GRATWOHL, A
    LORI, A
    OSTERWALDER, B
    NISSEN, C
    SPECK, B
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 1434 - 1436
  • [37] Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients
    Chiasson, Jordan M.
    Fominaya, Cory E.
    Gebregziabher, Mulugeta
    Taber, David J.
    TRANSPLANTATION, 2019, 103 (12) : 2675 - 2681
  • [38] Long term renal function of liver transplant recipients subjected to a renal protective immunosuppression with low-dose CNI combined with MMF plus steroids
    Guba, Markus
    Dubay, Derek
    McGilvary, Ian D.
    Cattral, Mark S.
    Lilly, Les
    Therapondous, George
    Renner, Eberhard
    Levy, Gary A.
    Greig, Paul D.
    Grant, David R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 328 - 329
  • [39] INFLUENCE OF REDUCED CYCLOSPORINE DOSE ON THE LONG-TERM COURSE IN RENAL-TRANSPLANT RECIPIENTS WITH ASSUMED CYCLOSPORINE TOXICITY
    KLIEM, V
    REPP, H
    FREI, U
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 486 - 487
  • [40] RECIPIENT PRETREATMENT PERMITS LONG-TERM XENOGRAFT SURVIVAL ON A RELATIVELY LOW-DOSE CYCLOSPORINE MAINTENANCE THERAPY
    BOUWMAN, E
    DEBRUIN, RWF
    JEEKEL, J
    MARQUET, RL
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (02) : 519 - 520